Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced an update to the prescribing information for ELEVIDYS , the only approved gene therapy for Duchenne...